Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sarcoma, Soft-tissue”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01858168
What this trial is testing

Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma

Who this might be right for
Ewing SarcomaRhabdomyosarcoma
Massachusetts General Hospital 49
Large-scale testing (Phase 3)UnknownNCT01087268
What this trial is testing

Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer

Who this might be right for
Bladder CancerCervical CancerColorectal Cancer+9 more
Royal Marsden NHS Foundation Trust 75
Testing effectiveness (Phase 2)Ended earlyNCT03524820
What this trial is testing

Cetuximab Therapy for Third Line Rechallenge in Metastatic Colorectal Cancer

Who this might be right for
Cancer of Colon
Hadassah Medical Organization 3
Early research (Phase 1)Study completedNCT00742924
What this trial is testing

Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma

Who this might be right for
Sarcoma
Children's Oncology Group 24
Not applicableStudy completedNCT05746429
What this trial is testing

Culturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric Cancer

Who this might be right for
Bone SarcomaChildhood Cancer
St. Jude Children's Research Hospital 68
Not applicableNot Yet RecruitingNCT07516353
What this trial is testing

My.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults

Who this might be right for
SarcomaOsteosarcomaEwing Sarcoma+6 more
Dana-Farber Cancer Institute 143
Testing effectiveness (Phase 2)Ended earlyNCT02113826
What this trial is testing

Pazopanib for Metastatic Alveolar Soft Part Sarcoma

Who this might be right for
Metastatic Alveolar Soft Part Sarcoma
Seoul National University Hospital 6
Testing effectiveness (Phase 2)Study completedNCT00003110
What this trial is testing

Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Case Comprehensive Cancer Center 5
Not applicableUnknownNCT01786889
What this trial is testing

Identification, Molecular Epidemiology Angiosarcoma of the Liver France

Who this might be right for
Angiosarcoma
Centre Oscar Lambret 9
Early research (Phase 1)Ended earlyNCT01204450
What this trial is testing

Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastomaSarcoma+1 more
UNC Lineberger Comprehensive Cancer Center 7
Early research (Phase 1)Study completedNCT01169584
What this trial is testing

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients

Who this might be right for
NeuroblastomaRhabdomyosarcomaLymphoma+2 more
Jennerex Biotherapeutics 6
Testing effectiveness (Phase 2)WithdrawnNCT00954876
What this trial is testing

Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Metastatic Wild Type Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Translational Genomics Research Institute
Testing effectiveness (Phase 2)Study completedNCT00148109
What this trial is testing

Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas

Who this might be right for
Sarcoma
University of Michigan Rogel Cancer Center 36
Testing effectiveness (Phase 2)Study completedNCT01005043
What this trial is testing

Therapy Trial to Determine the Safety and Efficacy of Heavy Ion Radiotherapy in Patients With Osteosarcoma

Who this might be right for
Osteosarcoma
University Hospital Heidelberg 23
Not applicableStudy completedNCT04008238
What this trial is testing

Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients

Who this might be right for
Soft Tissue Sarcoma AdultUndifferentiated Pleomorphic SarcomaEpithelioid Sarcoma+4 more
Institut Bergonié 29
Early research (Phase 1)Study completedNCT00132158
What this trial is testing

ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
GlioblastomaRhabdomyosarcomasNeuroblastoma+1 more
St. Jude Children's Research Hospital 19
Not applicableStudy completedNCT03022448
What this trial is testing

Geriatric Assessmen of Elderly "Unsuited" Patients Receiving Trabectedin in First Line Treatment For Advanced Soft Tissue Sarcomas (STS)

Who this might be right for
Advanced Soft-tissue SarcomaMetastatic Soft-tissue Sarcoma
GWT-TUD GmbH 72
Early research (Phase 1)Ended earlyNCT00311558
What this trial is testing

Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma

Who this might be right for
Cancer
The Cleveland Clinic 18
Testing effectiveness (Phase 2)Study completedNCT03213678
What this trial is testing

Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+30 more
National Cancer Institute (NCI) 18
Early research (Phase 1)Looking for participantsNCT07244835
What this trial is testing

DEG6498 in Participants With Solid Tumors

Who this might be right for
Malignant Neoplasms
Degron Therapeutics Co. 100
Next Page